An interventional study of vertical ramus osteotomy with iliac graft and bilateral sagittal splitting osteotomy in Mandibular Deficiency, sponsored by Fayoum University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-28.
Sponsored by Fayoum University · Not applicable, Interventional, and Treatment
26 studies on the registry are indexed under Micrognathism; 7 are open to participants now.
This study's planned enrollment of 20 is below the median of 24 across 22 interventional studies indexed under Micrognathism.
Browse Micrognathism studies →Fayoum University is the lead sponsor of 148 studies on the registry; 44 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Procedure: bilateral sagittal splitting osteotomy
Procedure: vertical ramus osteotomy with iliac graft
in the VRO group all patient will undergo vertical ramus osteotomy surgery with iliac graft to correct the sever mandibular defficiency
all patients in this group will undergo to bilateral sagittal split osteotomy to correct the sever mandibular deficiency
skeletal stability
Skeletal stability will be assessed by lateral cephalometric x-ray. It will be done pre operatively, immediate postoperative, and 6 months later
Time frame: 6 months
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.